These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cathecholamine in heart failure (author's transl)]. Yazaki Y; Ikeda M Kokyu To Junkan; 1975 May; 23(5):397-404. PubMed ID: 169560 [No Abstract] [Full Text] [Related]
3. Metabolism of the heart in health and disease. 3. Opie LH Am Heart J; 1969 Mar; 77(3):383-410. PubMed ID: 4237285 [No Abstract] [Full Text] [Related]
4. [Cardiac function failure and catecholamines]. Yasuda H Kokyu To Junkan; 1984 Nov; 32(11):1101-9. PubMed ID: 6097972 [No Abstract] [Full Text] [Related]
5. [Pathogenetic aspects of heart failure in spinal shock]. Galakhin KA Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):51-5. PubMed ID: 6624357 [TBL] [Abstract][Full Text] [Related]
6. [Neurohumoral mechanisms of the rat heart adaptation to overload]. Fedorov VN; Fateev MM; Sal'nikov EV; Sidorov AV Zh Evol Biokhim Fiziol; 2009; 45(4):398-402. PubMed ID: 19764636 [TBL] [Abstract][Full Text] [Related]
8. [Mechanical oscillations in the pathologically altered myocardium]. Vornovitskiĭ EG; Kaĭdash AN; Mogilevskiĭ EB; Bidkova ON Biull Eksp Biol Med; 1981 Jun; 91(6):658-61. PubMed ID: 7272479 [TBL] [Abstract][Full Text] [Related]
9. Catecholamines in normal and abnormal cardiac function. Manger WM Adv Cardiol; 1982; 30():1-145. PubMed ID: 6758499 [No Abstract] [Full Text] [Related]
10. [Relationship between level of endogenous catecholamines and contractile strength in normal and failing heart (rat heart-lung preparation) (author's transl)]. Panagia V; Minelli R G Ital Cardiol; 1973; 3(4):502-8. PubMed ID: 4767391 [No Abstract] [Full Text] [Related]
11. [Catecholamines and beta-blockers in heart failure: some physiopathological and pharmacological reflections]. Pasini E; Opasich C; Aquilani R Ital Heart J Suppl; 2000 Feb; 1(2):171-9. PubMed ID: 10731374 [TBL] [Abstract][Full Text] [Related]
14. [Catecholamines and the heart]. Moravec J Ann Med Interne (Paris); 1970 Oct; 121(10):797-806. PubMed ID: 4932839 [No Abstract] [Full Text] [Related]
15. [Metabolism in heart failure]. Gibiński K Pol Tyg Lek; 1968 Sep; 23(39):1493-7. PubMed ID: 5699164 [No Abstract] [Full Text] [Related]
16. [Role of intermediate metabolic changes in the mechanism of cardiac insufficiency and cardiac glycoside toxicity]. Pogosian LA Zh Eksp Klin Med; 1965; 5(3):31-6. PubMed ID: 5847709 [No Abstract] [Full Text] [Related]
17. [Studies on the positive inotropic mechanism of action of catecholamines]. Dietze G; von Funcke HJ; Hepp KD; Mehnert H Verh Dtsch Ges Kreislaufforsch; 1973; 39():157-61. PubMed ID: 4362191 [No Abstract] [Full Text] [Related]
18. [The lipid content of the myocardium as a function of cardiac work and of experimental cardiac insufficiency (rat heart-lung preparation)]. Minelli R; Panagia V; Sciorelli G Arch Sci Biol (Bologna); 1968; 52(3):254-62. PubMed ID: 5702571 [No Abstract] [Full Text] [Related]
19. [Myocardial metabolism of calcium in heart failure: from physiology to new therapeutic perspectives]. Casaburi C; Di Rella F; Riccio G; Angelillo N; Ettari G; Troise A; De Simone G; Longobardi S; Fazio S; Morgan JP; Cittadini A Ital Heart J Suppl; 2000 Jun; 1(6):766-71. PubMed ID: 11204008 [TBL] [Abstract][Full Text] [Related]
20. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart? Bridge JH; Savio-Galimberti E Circ Res; 2008 May; 102(9):995-7. PubMed ID: 18467636 [No Abstract] [Full Text] [Related] [Next] [New Search]